Treatment of cytokine release syndrome-induced vascular endothelial injury using mesenchymal stem cells.

Wang, Yuyan; Dong, Haibo; Dong, Tengyun; Zhao, Lulu; Fan, Wen; Zhang, Yu; Yao, Weiqi

Wang, Yuyan; Dong, Haibo; Dong, Tengyun; Zhao, Lulu; Fan, Wen; Zhang, Yu; Yao, Weiqi.

Afiliação

Wang Y; Department of Laboratory Medicine, The First Affiliated Hospital of Yangtze University, Jingzhou, China.
Dong H; Health Science Center, Yangtze University, Jingzhou, China.
Dong T; Wuhan Optics Valley Vcanbiopharma Co., Ltd, Wuhan, China.
Zhao L; Key Industrial Base for Stem Cell Engineering Products, Tianjin, China.
Fan W; Wuhan Optics Valley Vcanbiopharma Co., Ltd, Wuhan, China.
Zhang Y; Key Industrial Base for Stem Cell Engineering Products, Tianjin, China.
Yao W; Wuhan Optics Valley Vcanbiopharma Co., Ltd, Wuhan, China.

Mol Cell Biochem ; 2023 Jul 01.

Article em En | MEDLINE | ID: mdl-37392343

Palavras-chave

Cell therapy; Chimeric antigen receptor; Cytokine release syndrome; Mesenchymal stem cell; Vascular endothelial injury

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Cell Biochem Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google